These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6451052)

  • 1. Limiting dilution analysis of alloantigen-reactive cells which respond to allogeneic lymphocytes in human MLC and PLT.
    Singal DP; Naipaul N; Joseph S
    Tissue Antigens; 1980 Oct; 16(4):274-85. PubMed ID: 6451052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative studies of alloantigen-reactive human lymphocytes in primary and secondary MLC.
    Singal DP
    Hum Immunol; 1980 Jul; 1(1):67-76. PubMed ID: 6455394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specificity of secondary MLC assayed by titration of primed lymphocyte populations.
    Singal DP
    Tissue Antigens; 1979 Jul; 14(1):22-31. PubMed ID: 91217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the ABO, Secretor, and Lewis determinants in the primed lymphocyte test.
    Singal DP; Blajchman MA; Naipaul N; Joseph S
    Hum Immunol; 1981 May; 2(3):201-11. PubMed ID: 6167558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants.
    Wank R; Schendel DJ; Blanco ME; Dupont B
    Scand J Immunol; 1979; 9(6):499-505. PubMed ID: 88755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor specificity of alloreactive T cells. Distinction between stimulator K, I, and D region products and degeneracy of third-party H-2 recognition by low-affinity T cells.
    Nagy ZA; Elliott BE
    J Exp Med; 1979 Dec; 150(6):1520-37. PubMed ID: 159939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human cytotoxic lymphocyte responses. I. Non-cytolytic suppression mediated by alloantigen-activated cells.
    Crosier PS; Broom BC
    Immunology; 1981 May; 43(1):11-8. PubMed ID: 6454646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-restricted primary human histocompatibility leukocyte antigen (HLA)-specific cytotoxic T lymphocytes.
    Breur-Vriesendorp BS; Ivanyi P
    Int Immunol; 1993 Jan; 5(1):103-7. PubMed ID: 8443120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primed lymphocyte typing predicts MLC reactivity between unrelated individuals.
    Valentine-Thon E; Bach FH
    Tissue Antigens; 1983 Apr; 21(4):336-44. PubMed ID: 6222513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of alloantigen-primed lymphocytes in vitro. The specificity of secondary responses assayed by titration of primed lymphocyte populations.
    Corley RB
    Scand J Immunol; 1977; 6(5):547-53. PubMed ID: 882851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte activating alloantigens on human epidermal cells.
    Hirschberg H; Thorsby E
    Tissue Antigens; 1975 Oct; 6(4):183-94. PubMed ID: 53902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typing for MLC determinants: methods and applications.
    Thomsen M; Ryder LP; Svejgaard A
    Scand J Immunol; 1976 Jun; Suppl 5():157-74. PubMed ID: 79216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
    Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations.
    Garderet L; Snell V; Przepiorka D; Schenk T; Lu JG; Marini F; Gluckman E; Andreeff M; Champlin RE
    Transplantation; 1999 Jan; 67(1):124-30. PubMed ID: 9921808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen-induced enhancement and suppression of human cytotoxic lymphocyte responses to autologous lymphoblastoid cell lines.
    Zarling JM; Bach FH
    Scand J Immunol; 1978; 8(5):377-85. PubMed ID: 152971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restimulation in secondary MLC by autologous non-T cells.
    Zier KS; Huber C; Braunsteiner H
    Scand J Immunol; 1979; 9(6):493-8. PubMed ID: 156946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fetus as an allograft: evidence for antiidiotypic antibodies induced by pregnancy.
    Singal DP; Butler L; Liao SK; Joseph S
    Am J Reprod Immunol (1980); 1984 Dec; 6(4):145-51. PubMed ID: 6241427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting dilution analysis of alloantigen-reactive T lymphocytes. III. Effect of priming on precursor frequencies.
    Ryser JE; MacDonald HR
    J Immunol; 1979 Jul; 123(1):128-32. PubMed ID: 156230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.